ImmuCell Corporation (ICCC) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

ImmuCell Corporation (ICCC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $97.1M, listed on NASDAQ, employing roughly 73 people, carrying a beta of 0.57 to the broader market. ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U. Led by F. Olivier Te Boekhorst, public since 1987-05-05.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for ICCC as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →